Clinical Trial

Non-invasive Neuromodulation NESA Through Somatosensory Evoked Potentials and Sympathetic-cutaneous Responses

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 22, 2025 (before its estimated April 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Somatosensory evoked potentials are crucial in determining the physiological changes of potentials in nerve pathways. Although their main function is diagnostic, the investigators have recently been used as a physiological test to determine physioelectric changes in healthy subjects to study applied stimuli, such as laser, pain or electrotherapy.
Protocol Amendment History 17 amendments
This ClinicalTrials.gov record has been amended 17 times since 2021-07-14; most recent amendment 2025-08-21.
Trial Details
NCT Number NCT04962737
Lead Sponsor University of Las Palmas de Gran Canaria
Conditions Healthy Volunteers
Enrollment 15 participants
Start Date 2025-11-28
Primary Completion 2026-04-15 (estimated)
Study Completion 2026-10-20 (estimated)
Updated on ClinicalTrials.gov 2025-08-22